Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €60.99 | €86.77 | 42.271% |
| Merck & Co. Inc. | 28 | 1 | 3 | 0 | €122.00 | €124.93 | 2.401% |
| Eli Lilly Corp. | 51 | 0 | 7 | 0 | €723.40 | €766.92 | 6.016% |
| Amgen Inc. | 21 | 0 | 3 | 0 | €259.20 | €294.28 | 13.535% |
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.77 | - | - |
| Abbott Laboratories | 16 | 0 | 4 | 0 | €99.83 | €116.81 | 17.007% |
| Vertex Pharmaceuticals Inc. | 40 | 2 | 4 | 0 | €377.05 | €382.71 | 1.500% |
| Perrigo Co. plc | 3 | 0 | 1 | 0 | €30.77 | €35.99 | 16.949% |
| Zoetis Inc. A | 21 | 1 | 4 | 1 | €151.80 | €200.06 | 31.790% |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 7 | 1 | €845.00 | €957.22 | 13.280% |
| AbbVie Inc. | 20 | 1 | 3 | 1 | €151.00 | €174.43 | 15.519% |
| Biogen Inc. | 44 | 2 | 4 | 1 | €201.10 | €293.57 | 45.983% |